Article

Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular Correlates

2023-12-19

Abstract excerpt

<title>Abstract</title> <p>Therapeutic approaches targeting proteins on the surface of cancer cells have emerged as an important strategy for precision oncology. To fully capitalize on the potential impact of drugs targeting surface proteins, detailed knowledge about the expression patterns of the target proteins in tumor tissues is required. In castration-resistant prostate cancer (CRPC), agents targeting prosta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 12410bf1-e2aa-5439-a76e-3b33a0123656
DOI: 10.21203/rs.3.rs-3745991/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Assessment of Cell Surface Targets in Metastatic Prostate Cancer: Expression Landscape and Molecular CorrelatesDOI 10.21203/rs.3.rs-3745991/v1Read

Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlatesSemantic proximity Read

Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.Semantic proximity Read

Treatment-related Neuroendocrine Prostate Carcinoma—Diagnostic and Molecular CorrelatesSemantic proximity Read

Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling.Semantic proximity Read

L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells.Semantic proximity Read

Trop-2 plasticity is controlled by epithelial-to-mesenchymal transitionSemantic proximity Read

Spatial whole transcriptome profiling of primary tumor from patients with metastatic prostate cancerSemantic proximity Read

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancerSemantic proximity Read

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor GenesSemantic proximity Read

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumorSemantic proximity Read

TEAD1 regulates ITGA1 and ITGA2 to control prostate cancer progressionSemantic proximity Read

Cancer/Testis Antigens Differentially Expressed in Prostate Cancer: Potential New Biomarkers and Targets for ImmunotherapiesSemantic proximity Read